BTG3 and systemic lupus erythematosus: However, none of the ANA-positive participants met the 1982 ACR criteria necessary for the diagnosis of SLE, none with increased anti-TPO antibodies showed clinical manifestations of thyroid dysfunction and none of the AMA-positive individuals had clinical manifestations of liver disease.